Renal Cancer - Results from #5160

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma May 26, 2017

The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study May 26, 2017

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre. May 26, 2017

Incorporating New Systemic Therapies in Kidney Cancer Treatment May 25, 2017

Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers May 25, 2017

Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma May 25, 2017

Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma May 23, 2017

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience May 23, 2017

Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors May 22, 2017

Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures May 22, 2017

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors May 12, 2017

Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau May 11, 2017

Risk models for patients with localised renal cell carcinoma May 11, 2017

The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma May 10, 2017

Ultrasound-guided percutaneous radiofrequency ablation for treating small renal masses May 10, 2017

Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidence May 9, 2017

Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis. May 9, 2017

An Immune Atlas of Clear Cell Renal Cell Carcinoma. May 8, 2017

Optimum outcome achievement in partial nephrectomy for T1 renal masses: a contemporary analysis of open and robot-assisted cases. May 4, 2017

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma May 3, 2017

Page 259 of 456